Temozolomide Versus Irinotecan-Temozolomide For Children With Relapsed And Refractory High Risk Neuroblastoma (Rr-Hrnb): Results Of The Beaconneuroblastoma Randomized Phase 2 Trial A European Innovative Therapies For Children With Cancer (Itcc) - International Society Of Pediatric Oncology Europe Neuroblastoma Group (Siopen) Trial.

JOURNAL OF CLINICAL ONCOLOGY(2019)

引用 3|浏览62
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要